Free tool
FAERS Monitor: Oxderys
Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 221093 or its brand name (Oxderys, Doxorubicin Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
26,045
Serious
24,961
96% of reports
Hospitalization
10,285
Death reported
4,432
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use3,556
- febrile neutropenia3,192
- neutropenia1,978
- product use in unapproved indication1,597
- disease progression1,570
- pyrexia1,559
- anaemia1,264
- nausea1,254
- thrombocytopenia1,093
- vomiting1,048
- diarrhoea975
- drug ineffective892
- pneumonia891
- sepsis869
- white blood cell count decreased858
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 153 |
| 2005 | 198 |
| 2006 | 192 |
| 2007 | 375 |
| 2008 | 386 |
| 2009 | 161 |
| 2010 | 206 |
| 2011 | 407 |
| 2012 | 594 |
| 2013 | 512 |
| 2014 | 396 |
| 2015 | 796 |
| 2016 | 861 |
| 2017 | 1,028 |
| 2018 | 1,288 |
| 2019 | 1,453 |
| 2020 | 2,114 |
| 2021 | 1,729 |
| 2022 | 2,983 |
| 2023 | 3,234 |
| 2024 | 2,877 |
| 2025 | 2,351 |
| 2026 | 1,751 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,114 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| white blood cell count decreasedSignal | 858 | 6.4 | 6.0 | 3,922 |
| sepsisSignal | 869 | 6.3 | 5.9 | 3,888 |
| anaemiaSignal | 1,264 | 5.4 | 5.1 | 4,515 |
| product use in unapproved indicationSignal | 1,597 | 5.2 | 5.0 | 5,490 |
| pyrexiaSignal | 1,559 | 3.7 | 3.5 | 3,034 |
| off label useSignal | 3,556 | 3.3 | 3.2 | 5,884 |
| pneumoniaSignal | 891 | 2.2 | 2.1 | 608 |
| vomiting | 1,048 | 1.8 | 1.7 | 381 |
| nausea | 1,254 | 1.3 | 1.2 | 79 |
| diarrhoea | 975 | 1.2 | 1.1 | 40 |
| drug ineffective | 892 | 0.5 | 0.5 | 358 |
| febrile neutropenia | 3,192 | 0.0 | 0.0 | 2,576,727 |
| neutropenia | 1,978 | 0.0 | 0.0 | 1,596,332 |
| disease progression | 1,570 | 0.0 | 0.0 | 1,266,867 |
| thrombocytopenia | 1,093 | 0.0 | 0.0 | 881,700 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.